Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Gynecology

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 111 articles:
HTML format



Single Articles


    November 2021
  1. WANG X, Ouyang G, Chen Z, Fu L, et al
    Automatic Contouring of the Clinical Target Volume (CTV) for Cervical Cancer Adjuvant Radiotherapy Using Deep Learning Algorithm.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  2. KAWAHARA D, Nishibuchi I, Kawamura M, Yoshida T, et al
    Radiomic Analysis for Pretreatment Prediction of Recurrence after Radiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  3. HAMADE DF, Epperly M, Fisher R, Hou W, et al
    Second-Generation Probiotic Lactobacillus Reuteri Producing IL-22 (LR-IL-22) Protects the Intestine to Facilitate Whole Abdomen Irradiation (WAI) in Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  4. YU E, DiPetrillo TA, Koffer PP, Miller CJ, et al
    Hospital Database Validation of PORTEC3 Stage-Based Overall Survival Benefit for Chemoradiation Therapy in Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  5. WEIL C, Lew F, Gaffney DK, Suneja G, et al
    Patterns of Practice for Adjuvant Treatment of FIGO 1B Grade 3 Endometrial Adenocarcinoma Following Publication of ASTRO 2014 Guidelines for Postoperative Treatment in Women With Early Stage High Risk Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  6. WANG W, Zou L, Wang T, Liu Z, et al
    Treatment Optimization of Pelvic External Beam Radiation With/or Vaginal Brachytherapy for Patients with Stage I to II High-Risk Endometrioid Adenocarcinoma: A Retrospective Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  7. SUN S, Zou L, Wang T, Liu Z, et al
    Age >/=60 y May Not be an Appropriate Adverse Risk Factor in Adjuvant Treatment of Patients With Early-Stage Endometrial Carcinoma: A Multi-Institutional Analysis in China.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  8. RUSSO AL, Bernstein KD, Nisbet SP, Horick N, et al
    Phase II Study of Adjuvant Scanned Proton Beam Radiation Therapy for Node-positive Cancer of the Uterus and Cervix.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  9. REN K, Zou L, Wang T, Li X, et al
    Long-Term Outcome and Failure Patterns in Early-Stage Endometrial Cancer After Postoperative Adjuvant Radiotherapy: A Multi-Institutional Analysis Update Data.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  10. PATEL G, Rivera A, Brodin P, Velten C, et al
    Outcomes of Definitive Radiation Therapy for Inoperable Endometrial Cancer and Dosimetric Comparison Study of HDR Brachytherapy vs. SBRT Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  11. NGANGA D, Hoover A
    Visceral Adipose Volume as a Predictor for Acute Bowel Toxicity in Patients Receiving Adjuvant Intensity-Modulated Radiation Therapy for Cervical or Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  12. IKIZLER O, Ko HC
    Outcomes after Definitive Surgery +/- Adjuvant Treatment for Invasive and Non-Invasive FIGO Stage IA Malignant Mixed Mullerian Tumor of the Endometrium.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  13. HUI C, Mendoza M, Von Eyben R, Hammer P, et al
    Does Lymph Node Assessment Change the Prognostic Significance of Extensive LVSI and p53 Mutation in Endometrial Cancer?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  14. MERFELD E, Huang JY, Kuczmarska-Haas A, Desai V, et al
    Targeting the GTV in Medically Inoperable Endometrial Cancer Using Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  15. COOK AE, Ghanem AI, Hijaz M, Burmeister C, et al
    Patterns of Recurrence After Adjuvant Vaginal Cuff Brachytherapy and Chemotherapy in Early-Stage Uterine Serous Carcinoma.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  16. BYLUND KC, Chowdhry AK, Nguyen K, Geevarghese S, et al
    Effect of Adjuvant Radiation and Chemotherapy in Localized Uterine Carcinosarcoma: A National Cancer Database Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  17. CASPER AC, Parsons MW, Chipman J, Burt LM Jr, et al
    Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-up.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  18. ANDERSON E, Luu M, Lu DJ, Chung EM, et al
    Pathologic Primary Tumor Factors Associated With Risk of Lymph Node Involvement in Patients With High-Risk Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  19. POLLOCK AE, Risher H, Bentzen SM, Roque DM, et al
    Clinical Outcomes of Patients Treated With Intensity Modulated Proton Therapy (IMPT) Re-Irradiation for Gynecologic Malignancies.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  20. CORRIGAN KL, Yoder AK, Lin LL, Jhingran A, et al
    Long-Term Survival Following Definitive Radiation Therapy for Oligometastases in Gynecological Malignancies: A Landmark Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  21. ZHOU Z, Zhang F, Hu K
    High Dose Radiotherapy Combined With TGF-beta Blocking Alleviate Cervical Cancer Cell-Suppressed Dendritic Cell Homing Through PGE2 Pathway.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  22. AMARNATH SR
    Is Inflammatory Bowel Disease a Contraindication for Pelvic XRT in Patients With Gynecologic Cancers? Efficacy and Toxicity Outcomes in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  23. YANG H, Zhang Y, Liu C, Zhao L, et al
    Combined Modality of Bevacizumab With Radical Radiotherapy and Chemotherapy in the Treatment of Refractory Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  24. WU J, Lakomy DS, Fellman B, Salcedo MP, et al
    Bone Mineral Density Changes Within and Outside of RT Fields Used to Treat Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  25. WILLIAMSON CW, Kotha NV, Morris K, Simoes-Torigoe R, et al
    Radiation-Induced Vaginal Stenosis in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  26. WEIL C, Parsons MW, Chipman J, Kraus RD, et al
    Secondary Malignancy Risk in Cervical Cancer Survivors After 40 Years of Follow-Up Stratified by Treatment Modality and Radiation Technique.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  27. WANG D, Hu K, Zhang F
    Impact of Body Mass Index and Abdominal Subcutaneous Fat Thickness of Setup Errors in Postoperative Cervical Cancer Patients Underwent Daily Image-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  28. WEI C, Franco II, Orio PF 3rd, Mak RH, et al
    Comparison of Cost vs. Reimbursement for Definitive Radiotherapy in Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  29. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
    Trends in Guideline-Adherent Chemoradiation Therapy for Locally Advanced Cervical Cancer Before and After the Affordable Care Act.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  30. SAITO AI
    Curative Radiotherapy for Stage IVB or Recurrent Uterine Cancer Presenting With Supraclavicular or Mediastinal Lymph Node Metastasis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  31. SHI V, Huang Y, Grigsby PW, Markovina S, et al
    Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  32. RAHIMY E, Von Eyben R, Lewis J, Hristov DH, et al
    Dosimetric and Metabolic Parameters Predictive of Hematologic Toxicity in Cervical Cancer Patients Undergoing Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  33. PINTO PJJ, Favareto SL, Souza CFPM, Baiocchi G, et al
    Do Radiotherapy Planning Factors Influence Para-Aortic Recurrence in IIIC1 Cervical Cancer Patients?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  34. PACHIGOLLA SL, Markovina S, Lin AJ, Schwarz JK, et al
    Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  35. ONAL C, Guler OC, Reyhan M, Yapar AF, et al
    Long-Term Outcomes of Cervical Cancer Patients With Complete Metabolic Response After Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  36. PACHIGOLLA SL, Massad LS, Thaker P, Mutch D, et al
    A Nomogram Predicting Early Cervical Cancer Distant Recurrence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  37. OKONOGI N, Ando K, Murata K, Wakatsuki M, et al
    The Clinical Results in Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients With Locally Advanced Adenocarcinoma of the Uterine Cervix.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  38. NISHIBUCHI I, Kawahara D, Kawamura M, Kubo K, et al
    A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  39. PUENTES CYM, Banks T, Hrycushko BA, Jia X, et al
    Multidisciplinary Consensus and Evaluation of Gynecological High-Dose-Rate (HDR) Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  40. LIU C, Li A, Wang C, Zou W, et al
    Intratumor Microbiome and Its Correction With Tumor Response After Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  41. LI F, Li J, Yin S, Mei F, et al
    A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump >/=4 cm).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  42. LI J, Mao W, Li F, Ran L, et al
    A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  43. KOTHA NV, Williamson CW, McHale M, Mell LK, et al
    Ineligible and Incomplete Cisplatin Regimens in Chemoradiation Treatment for Patients With Locally Advanced Cervical Cancer: A Population for Survival Improvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  44. LEE TH, Kim IA, Kim JS Jr, Song C, et al
    Stereotactic Ablative Body Radiotherapy Boost for Cervical Cancer When Brachytherapy Boost is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  45. KIM KH, Chang JS, Kim YB
    A Novel Gene Signature Associated With Poor Response to Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  46. KOERNER SA, Baig T, Kim H, Rodriguez-Lopez JL, et al
    Can We Avoid Ureters as Organs at Risk With MRI-Based Brachytherapy for Cervical Cancer? A Dosimetric Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  47. GJYSHI O, Grippin A, Boyce-Fappiano D, Jhingran A, et al
    Circulating and Tumor-Associated Neutrophils Function as a Powerful Biomarker for Response to Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  48. HOLLIS ES, Ruebush E, Davies E, Paraghamian S, et al
    Smoking Cessation Interventions During Chemoradiotherapy for Locally Advanced Cervical Cancer: A Missed Opportunity?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  49. GEORGE J, Tuli S, Monare B, Lichter K, et al
    Stage and Outcomes of Cervical Cancer With or Without HIV Infection in Botswana 2013-2020.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  50. FREIJE S, Steele EM, Robertson SE, Ishaq O Jr, et al
    Medicaid Expansion Through the Affordable Care Act and Receipt of Guideline Recommended Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  51. DING S, Liu H, Wang B, Li Y, et al
    Inter- and Intrafraction Bladder and Rectum Motion in Patients With Cervical Cancer Under MR-Guided Radiotherapy on a 1.5T MR-Linac.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  52. COUSINS DF, Sanders J, Muller DA, Ward KA, et al
    Disease Characteristics and Patterns of Failure by Histologic Type for Patients Treated With Definitive Radiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  53. D'CUNHA P, Gonzalez Y, Nwachukwu CR, Hrycushko BA, et al
    Change in Image-Guided Planning Strategies Over Time Impacts Global Outcomes for Intracavitary Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  54. MORCOS M, Bhatia R, Li K, Viswanathan AN, et al
    Prospective Trial of Hydrogel Visualization and Dosimetric Effects on Rectum and Tumor Dose in Gynecologic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  55. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Toxicity Related Patients Factors and Bevasizumab Use in Patients With Locally Advanced Cervical Cancer Treated With Definitive Chemoradiation and HDR Brachytherapy Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  56. CHEN Y, Sun C, Li Q, Tang H, et al
    The Effect of Bulk Electron Density on the Accuracy of Treatment Planning for Postoperative Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  57. CHOQUE R, Aviles L, Rosas M, Suarez R, et al
    PET CT Based Stereotactic Body Radiosurgery (SBRT) in Non-Metastatic Cervical Cancer. The First Bolivian Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  58. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Racial Disparities in Time to Start of Definitive Radiation Treatment for Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  59. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Disparities and Health Access in Brachytherapy Boost Administration in Woman With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  60. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
    Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  61. SHIAO JC, Santoso A, Stuhr K, Bennett S, et al
    Gynecologic Interstitial Brachytherapy Curriculum Using a Low-Cost Phantom With Ultrasound Workshop and a Treatment Planning Workshop is Feasible and Effective.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  62. ORIAN IB, Symon Z, Appel S, Nof EL, et al
    The Impact of Radiation Therapy on Obstetric Complications in Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  63. URBAN R, Wong J, Lim P, Zhang S, et al
    Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  64. TARIQ M, Denniston KA
    EQD2 Dose Accumulation Based on Deformable Image Registration of HR-CTV, Bladder, Rectum and Bowel for Combined External-Beam Radiotherapy and Brachytherapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  65. GAY C, Raphael Y, Steers J, Lu DJ, et al
    Ovarian Transposition Prior to Pelvic Radiotherapy: Spatial Distribution and Dose Volume Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  66. YEN A, Morgan HE, Wang K, Albuquerque KV, et al
    Interpretable Machine Learning Model Supported by Parallel Ensemble Learning to Predict Local Recurrence for Patients with Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  67. REIJTENBAGH DMW, Godart J, De Leeuw A, Seppenwoolde Y, et al
    A Machine-Learning Based Method for Inter-Institutional QA of MR-Based Brachytherapy Treatment Planning in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  68. LIU C, Wang C, Hu X, Zou W, et al
    Dissecting Concurrent Chemoradiotherapy-Induced Landscape Alteration of Tumor Microenvironment in Locally Advanced Cervical Cancer at Single Cell Resolution.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  69. WANG W, Hu K, Zhang F
    Prophylactic Extended-Field Irradiation vs. Pelvic Irradiation in Cervical Cancer Patients With 2018 FIGO IIIC1 Diseases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  70. HAN K, Fyles TW, Shek T, Croke JM, et al
    Chemoradiation With or Without Metformin in Locally Advanced Cervical Cancer: Phase II Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  71. ROBIN TP, Hu J, Jones BL, Patton TJ, et al
    Phase I Dose Escalation Clinical Trial of Stereotactic Body Radiation Therapy (SBRT) for Limited Locoregional Recurrences of Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  72. LEUNG EW, Gladwish AP, Davidson MTM, Taggar A, et al
    Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus (SPARTACUS): A Multicenter Prospective Trial Evaluating Acute Toxicities and Patient Reported Outcomes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  73. ZHANG Y, Liu C, Yang H, Shi M, et al
    Weekly Cisplatin vs. Triweekly Docetaxel Plus Cisplatin With Concurrent Chemoradiation in Post-Operative Treatment for Cervical Cancer With High-Risk Pathological Factors: A Randomized Controlled Phase III Trial From a Single Institution.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  74. ROGACKI K, Wray B, Donnelly ED
    Gene Expression and Mutation Analysis of Early-Stage Recurrent Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  75. LI JY, Park HSM, Huang G, Young MR, et al
    Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  76. LAKOMY DS, Wu J, Yoder AK, Hernandez M, et al
    Impact of Treatment Modality on Pelvic Floor Dysfunction for Uterine Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  77. DONOVAN E, Albuquerque KV, Mantz CA, Beriwal S, et al
    The Role of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic and Oligoprogressive Gynecologic Malignancies: A Multi-Institutional Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  78. ROVIROSA A SR, Zhang Y, Chargari C, Cooper R, et al
    3D Image-Guided Brachytherapy as Only Treatment for Stage-I Inoperable Endometrial Cancer: Retrospective Analysis of the Gynecological Cancer GEC-ESTRO Working Group.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  79. NDUMBALO J, Muya S, Nyagabona SK, Yusuph S, et al
    Continuing Education Needs Identified During the Initial Experience of Delivering 3D Conformal Radiotherapy for Cervical Cancer Patients in Tanzania.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  80. YANEY A, Mladkova N, Quick AM
    Clinical and Genomic Determinants of Survival in Ugandan Women With Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  81. BHATIA R, Ramogola-Masire D, Friebel-Klingner T, Monare B, et al
    Cervical Cancer Screening in Botswana: An Urgent Call for Guideline Change.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


    October 2021
  82. SPAMPINATO S, Jensen NBK, Potter R, Fokdal LU, et al
    Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future.
    Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02915.
    PubMed     Abstract available


  83. DAMAST S, Fields E, Kidd E, Harkenrider M, et al
    Reports From Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111:299-306.
    PubMed    


    August 2021
  84. KIRCHHEINER K, Smet S, Jurgenliemk-Schulz IM, Haie-Meder C, et al
    Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes in locally advanced cervical cancer patients after definitive chemoradiotherapy - results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2021 Aug 31. pii: S0360-3016(21)02729.
    PubMed     Abstract available


  85. HENKE LE, Stanley JA, Robinson C, Srivastava A, et al
    Phase I Trial of Stereotactic MRI-guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Aug 30. pii: S0360-3016(21)02726.
    PubMed     Abstract available


    June 2021
  86. KIM H, Lee YC, Benedict SH, Dyer B, et al
    Dose summation strategies for external beam radiation therapy and brachytherapy in gynecologic malignancy: a review from the NRG Oncology and NCTN medical physics subcommittees.
    Int J Radiat Oncol Biol Phys. 2021 Jun 17. pii: S0360-3016(21)00737.
    PubMed     Abstract available


  87. MAHANTSHETTY U, Gurram L, Bushra S, Ghadi Y, et al
    Single application multi-fractionated image guided adaptive High Dose Rate Brachytherapy for Cervical Cancer- Dosimetric & Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2021 Jun 16. pii: S0360-3016(21)00732.
    PubMed     Abstract available


    April 2021
  88. STURDZA AE, Poetter R, Kossmeier M, Kirchheiner K, et al
    Nomogram predicting overall survival in locally advanced cervical cancer patients treated by radio-chemotherapy including image guided brachytherapy: a Retro-EMBRACE study.
    Int J Radiat Oncol Biol Phys. 2021 Apr 28. pii: S0360-3016(21)00404.
    PubMed     Abstract available


    March 2021
  89. CHAUDARY N, Hill RP, Stulik L, Milosevic M, et al
    The oral CXCR4 inhibitor X4-136 improves tumor control and reduces toxicity in cervical cancer treated with radiotherapy and concurrent chemotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Mar 23. pii: S0360-3016(21)00291.
    PubMed     Abstract available


  90. LI R, Liu Y, Yin R, Yin L, et al
    The Dynamic alternation of Local and Systemic Tumor Immune Microenvironment during Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00243.
    PubMed     Abstract available


  91. HATHOUT L, Wang Y, Wang Q, Vergalasova I, et al
    A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women with Stage IIIC Endometrial Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 4. pii: S0360-3016(21)00240.
    PubMed     Abstract available


  92. K JENSEN NB, Potter R, Spampinato S, Fokdal LU, et al
    Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
    Int J Radiat Oncol Biol Phys. 2021;109:688-700.
    PubMed     Abstract available


    February 2021
  93. DATTA NR, Stutz E, Gomez S, Bodis S, et al
    In Reply to Roussakow.
    Int J Radiat Oncol Biol Phys. 2021;109:642-644.
    PubMed    


  94. ROUSSAKOW S
    In Regard to Datta et al.
    Int J Radiat Oncol Biol Phys. 2021;109:641-642.
    PubMed    


    December 2020
  95. RAUT A, Chopra S, Mittal P, Patil G, et al
    FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:1248-1256.
    PubMed     Abstract available


  96. YUSUFALY T, Miller A, Medina-Palomo A, Williamson CW, et al
    A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:1240-1247.
    PubMed     Abstract available


    November 2020
  97. FEDERICO C, Sun J, Muz B, Alhallak K, et al
    Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side-Effect Profile.
    Int J Radiat Oncol Biol Phys. 2020 Nov 27. pii: S0360-3016(20)34592.
    PubMed     Abstract available


  98. BERGER T, Godart J, Jagt T, Vittrup AS, et al
    DOSIMETRIC IMPACT OF INTRA-FRACTION MOTION IN ONLINE-ADAPTIVE IMPT FOR CERVICAL CANCER.
    Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34559.
    PubMed     Abstract available


  99. ARYA R, Golden DW
    A Curious Case of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:846-847.
    PubMed    


  100. CHINO J, Damast S, Kidd E, Harkenrider M, et al
    Radiation for Cancers of the Uterine Corpus and Cervix: Incremental Steps, and Glimmers of the Future.
    Int J Radiat Oncol Biol Phys. 2020;108:839-845.
    PubMed    


  101. DYER BA, Mayadev JS
    Restage and Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:849-850.
    PubMed    


  102. SON CH, Hasan Y
    A Parametrial Problem.
    Int J Radiat Oncol Biol Phys. 2020;108:849.
    PubMed    


  103. SINGER L, Lee LJ
    50 Gray is Not Enough.
    Int J Radiat Oncol Biol Phys. 2020;108:848-849.
    PubMed    


  104. RIGAUD B, Anderson BM, Yu ZH, Gobeli M, et al
    Automatic segmentation using deep learning to enable online dose optimization during adaptive radiotherapy of cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 9. pii: S0360-3016(20)34484.
    PubMed     Abstract available


  105. MAO X, Pineau J, Keyes R, Enger SA, et al
    RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    Int J Radiat Oncol Biol Phys. 2020;108:802-812.
    PubMed     Abstract available


    October 2020
  106. POST CCB, de Boer SM, Powell ME, Mileshkin L, et al
    Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial.
    Int J Radiat Oncol Biol Phys. 2020 Oct 28. pii: S0360-3016(20)34447.
    PubMed     Abstract available


  107. NGOI NY, Heong V, Tang JI, Choo BA, et al
    Phase I study of low-dose fractionated whole abdominal radiation therapy in combination with weekly paclitaxel for platinum-resistant ovarian cancer (GCGS-01).
    Int J Radiat Oncol Biol Phys. 2020 Oct 9. pii: S0360-3016(20)34384.
    PubMed     Abstract available


  108. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    


    July 2020
  109. PARRY MG, Nossiter J, Cowling TE, Sujenthiran A, et al
    Toxicity of pelvic lymph node irradiation with intensity modulated radiation therapy for high-risk and locally advanced prostate cancer: a national population-based study using patient-reported outcomes.
    Int J Radiat Oncol Biol Phys. 2020 Jul 24. pii: S0360-3016(20)31450.
    PubMed     Abstract available


  110. WANG Y, Chen H
    In Reply to Ghadjar et al.
    Int J Radiat Oncol Biol Phys. 2020;107:856.
    PubMed    


  111. GHADJAR P, Beck M, Zschaeck S, Wust P, et al
    In Regard to Wang et al.
    Int J Radiat Oncol Biol Phys. 2020;107:855.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: